Standard BioTools Retained Earnings (Accumulated Deficit) 2010-2024 | LAB
Standard BioTools retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Standard BioTools Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-1,001 |
| 2022 | $-926 |
| 2021 | $-736 |
| 2020 | $-677 |
| 2019 | $-624 |
| 2018 | $-559 |
| 2017 | $-500 |
| 2016 | $-439 |
| 2015 | $-363 |
| 2014 | $-310 |
| 2013 | $-257 |
| 2012 | $-241 |
| 2011 | $-222 |
| 2010 | $-199 |
| 2009 | $-182 |
| Standard BioTools Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-1,152 |
| 2024-06-30 | $-1,125 |
| 2024-03-31 | $-1,079 |
| 2023-12-31 | $-1,001 |
| 2023-09-30 | $-981 |
| 2023-06-30 | $-960 |
| 2023-03-31 | $-943 |
| 2022-12-31 | $-926 |
| 2022-09-30 | $-905 |
| 2022-06-30 | $-876 |
| 2022-03-31 | $-812 |
| 2021-12-31 | $-736 |
| 2021-09-30 | $-727 |
| 2021-06-30 | $-713 |
| 2021-03-31 | $-696 |
| 2020-12-31 | $-677 |
| 2020-09-30 | $-659 |
| 2020-06-30 | $-653 |
| 2020-03-31 | $-640 |
| 2019-12-31 | $-624 |
| 2019-09-30 | $-611 |
| 2019-06-30 | $-598 |
| 2019-03-31 | $-584 |
| 2018-12-31 | $-559 |
| 2018-09-30 | $-544 |
| 2018-06-30 | $-529 |
| 2018-03-31 | $-513 |
| 2017-12-31 | $-500 |
| 2017-09-30 | $-490 |
| 2017-06-30 | $-474 |
| 2017-03-31 | $-457 |
| 2016-12-31 | $-439 |
| 2016-09-30 | $-422 |
| 2016-06-30 | $-402 |
| 2016-03-31 | $-383 |
| 2015-12-31 | $-363 |
| 2015-09-30 | $-351 |
| 2015-06-30 | $-341 |
| 2015-03-31 | $-326 |
| 2014-12-31 | $-310 |
| 2014-09-30 | $-299 |
| 2014-06-30 | $-285 |
| 2014-03-31 | $-273 |
| 2013-12-31 | $-257 |
| 2013-09-30 | $-253 |
| 2013-06-30 | $-248 |
| 2013-03-31 | $-244 |
| 2012-12-31 | $-241 |
| 2012-09-30 | $-237 |
| 2012-06-30 | $-233 |
| 2012-03-31 | $-228 |
| 2011-12-31 | $-222 |
| 2011-09-30 | $-218 |
| 2011-06-30 | $-214 |
| 2011-03-31 | $-207 |
| 2010-12-31 | $-199 |
| 2010-09-30 | $-196 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.596B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.226B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
| Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
| Enovis (ENOV) | United States | $2.608B | 17.68 |
| Privia Health (PRVA) | United States | $2.587B | 215.60 |
| IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
| Azenta (AZTA) | United States | $2.209B | 110.15 |
| Omnicell (OMCL) | United States | $2.116B | 69.23 |
| 10x Genomics (TXG) | United States | $1.732B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.518B | 0.00 |
| Phreesia (PHR) | United States | $1.148B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
| Talkspace (TALK) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| TruBridge (TBRG) | United States | $0.247B | 71.91 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |